The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced CancerToshio Shimizu, Amita Patnaik, Cathy Alvarez et al.|Clinical Cancer Research|2012Cited by 432
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S.John R. MacDonald, Daniel D. Von Hoff, Michael J. Kelner et al.|PubMed|1997Cited by 109